In a mouse model of obesity, using UCB-MSCs, we showed that melatonin treatment improved the efficacy of stem cell transplantation therapy, which was abolished following ABCA1 inhibition. This evidence concerns the gene ABCA1 and obesity due to melanocortin 4 receptor deficiency.